IDO1 and neoplasm: Hu et al. developed a negatively charged HA, which can achieve graded nanostructures and effectively deliver celastrol (a pentacyclic triterpenoid extracted from traditional Chinese medicine) and 1-methyltryptophan (IDO inhibitor) to a deep tumor site of the pancreas.